Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Stability Indicating HPLC-DAD Method for the Determination of Oxcarbazepine-An Anticonvulsant


Affiliations
1 Department of Pharmaceutical Ananlysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM(Deemed to be University), Vishakapatnam, Andhra Pradesh-530045, India
     

   Subscribe/Renew Journal


Oxcarbazepine is an anticonvulsant drug used for the treatment of epilepsy. It acts by decreasing the abnormal electrical activity in the brain. A new stability indicating HPLC method was developed for the quantification of Oxcarbazepine in tablets. Waters e2695 Separations module with Waters 2489 UV detector with Hypersil BDS C18 column (250 mm x 4.6 mm, 5μ) was operated with column temperature 50°C. The detector was monitored at 215 nm and the chromatographic study was run for 20 min. Linearity was observed over 5.0-150 μg/mL with linear regression equation y = 47,910x + 6493.8 with correlation coefficient R² = 0.9999. The LOQ and LOD were found to be 4.5129 μg/mL and 1.4898 μg/mL respectively. Forced degradation studies were performed for Oxcarbazepine capsules and the method was validated as per ICH guidelines.

Keywords

Oxcarbazepine, RP-HPLC, Stability Indicating, Validation, ICH Guidelines.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Brazilian Pharmacopoeia. 4th edition. São Paulo: Atheneu. 1988.

  • Flesch G. Overview of the clinical pharmacokinetics of oxcarbazepine. Clinical Drug Investigation. 24; 2004: 185-203.

  • Rajendraprasad N, Basavaiah K, Cijo MX, Vinay KB, Ramesh PJ. Development and validation of stability indicating spectrophotometric methods for the determination of Oxcarbazepine in pharmaceuticals. Journal of Scientific and Industrial Research. 70; 2011: 346-351.

  • Ramaa CS, Chothe PP, Naik AA, Kadam VJ. Spectrophotometric method for the estimation of Oxcarbazepine in tablets. Indian Journal of Pharmaceutical Sciences. 68; 2006: 265- 266.

  • Gandhimati M, Ravi TK. Use of Folin- Ciocalteu phenol reagent and 3-methyl-2- benzothiazolinone hydrazine HCl in the determination of Oxcarbazepine in pharmaceuticals. Acta Pharmaceutica. 58; 2008: 111-118.

  • Satish MA, Nagendrappa G. Spectrophotometric determination of Oxcarbazepine in pharmaceutical formulation. International Journal of Pharmaceutical Sciences. 98; 2010: 293.

  • Murali Krishna Ch, Venkata Rao CV, Malleswara Rao NVS, Rambabu C. Spectrophotometric determination of Oxcarbazepine by condensation reactions using 2-chlorophenylhydrazine and anthranilic acid Journal of Pharmacy Research. 10(4); 2011: 3317-3319.

  • Paula Cristina, Rezende EnÈas, Renata Barbosa de Oliveira, GersonAntÙnio Pianetti. Oxcarbazepine: Validation and application of an analytical method. Brazilian Journal of Pharmaceutical Sciences. 46(2), 265-272 (2011).

  • Calvo MEB, Renedo OD, MartÌnez MJA. Determination of Oxcarbazepine by square wave ad sorptive stripping voltammetry in pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis. 43(3); 2007: 1156- 1160.

  • Pratima AT, Supriya SJ, Satish YG. Development and validation of a novel HPTLC method for simultaneous estimation of Beta-Sitosterol-D-Glucoside and Withaferin A. International Journal of Pharmacy and Pharmaceutical Sciences. 3(2); 2011: 227-230.

  • Pawar RK, Sharma Shivani, Singh KC, Sharma Rajeev KR. Development and validation of HPTLC method for the determination of Andrographolide in Kalmegh Navayas Lohaan ayurvedic formulation. International Journal of Pharmaceutical Sciences. 3(2); 2011: 85- 89.

  • Reddy TS, Devi PS. Validation of a high performance thin layer chromatographic method with densitometric detection for quantitative analysis of two anticonvulsants in tablets. Journal of Planar Chromatography Modern TLC. 20; 2007; 451-456.

  • Greiner-Sosanko E, Giannoutsos S, Lower DR, Virji MA, Krasowski MD. Drug monitoring: Simultaneous analysis of lamotrigine, Oxcarbazepine, 10- hydroxycarbazepine and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetum, Journal of Chromatographic Science. 45; 2007: 616-622.

  • VonUnruh GE, Paar WD. Gas chromatographic/ mass spectrometric assays for Oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10, 11trans-diol. Biomedical Environment Mass Spectrometry. 13(12); 1986: 6516.

  • Von Unruh GE, Paar WD. Gas chromatographic assay for Oxcarbazepine and its main metabolites in plasma, Journal of Chromatography. 345(1); 1985: 67-76.

  • Maurer HH, Kratzsch C, Weber AA, Peters FT, Kraemer T. Validated assay for quantification of Oxcarbazepine and its active dihydro metabolite 10- hydroxyl carbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry, Journal of Mass Spectrometry. 37(7); 2002: 687-92.

  • Klys M, Rojek S, Bolechala F. Determination of Oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). Journal of Chromatography B: Analyt Technology Biomedical Life Sciences. 825(1); 2005: 38-46.

  • Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire BD. Liquid chromatography electro spray mass spectrometry determination of Carbamazepine, Oxcarbazepine and their metabolites in human plasma. Journal of Chromatography B: Analyt Technology Biomedical Life Sciences. 828(1-2); 2005: 80-90.

  • Lanckmans K, Clinckers R, Van Eeckhaut A, Sarre S, Smolders I, Michotte Y. Use of microbore LC-MS/MS forthe quantification of Oxcarbazepine and its active metabolite in rat brain microdialysis samples. Journal of Chromatography B: Analyt Technology Biomedical Life Sciences. 831(1-2); 2006: 205-212.

  • Pucci V, Kenndler E, Raggi MA. Quantitation of Oxcarbazepine and its metabolites in human plasma by micellar electrokinetic chromatography. Biomedical Chromatography 17(4), 231-8 (2003).

  • Matar KM, Nicholls PJ Al Hassan MI and Tekle A. Rapid micro method for simultaneous measurement of Oxcarbazepine and its active metabolite in plasma by high-performance liquid chromatography. Journal of Clinical Pharmacy and Therapeutics. 20(4); 1995: 229-234.

  • Levert H, Odou P, Robert H. LC determination of Oxcarbazepine and its active metabolite in human serum. Journal of Pharmaceutical and Biomedical Analysis. 28(3-4); 2002: 517-525.

  • Juenke JM, Brown PI, Urry FM, McMillin GA. Drug monitoring and toxicology: A procedure for the monitoring of Oxcarbazepine metabolite by HPLC- UV. Journal of Chromatographic Science. 44; 2006: 45-48.

  • Levert H, Odou P, Robert H. Simultaneous determination off our antiepileptic drugs in serum by high- performance liquid chromatography. Biomedical Chromatography. 16(1); 2002: 19-24.

  • Rouan MC, Decherf M, Le Clanche V, Lecaillon JB and Godbillon J. Automated microanalysis of Oxcarbazepine and its monohydroxy and trans diol metabolites in plasma by liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 658(1): 1994: 167-72.

  • Mandrioli R, Ghedini N, Albani F, Kenndler E, Raggi MA. Liquid chromatographic determination of Oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction. Journal of Chromatography B: Analyt Technology Biomedical Life Sciences.783(1): 2003: 253-263.

  • Manuela Contin, Monica Balboni, Erica Callegati, Carmina Candela, Fiorenzo Albani, Roberto Riva, Agostino Baruzzi. Simultaneous liquid chromatographic determination of lamotrigine, Oxcarbazepine mono hydroxy derivative and felbamate in plasma of patients with epilepsy. Journal of Chromatography B: Analyt Technology Biomedical Life Sciences. 828(1-2); 2005: 113-117.

  • Van Belle K, Dekoster V, Sarre S, Ebinger G, Michotte Y. Liquid chromatographic assay using a micro column coupled to a U-shaped optical cell for high-sensitivity ultraviolet absorbance detection of Oxcarbazepine and its major metabolite in micro dialysates. Journal of Chromatography B: Biomedical Sciences and Applications. 657(1); 1994: 149-154.

  • Menge GP, Dubois JP, Bauer G. Simultaneous determination of Carbamazepine, Oxcarbazepine and their main metabolites in plasma by liquid chromatography. Journal of Chromatography. 414(2); 1987: 477-483.

  • Saracino MA, Tallarico K, Raggi MA. Liquid chromatographic analysis of Oxcarbazepine and its metabolites in plasma and saliva after a novel micro extraction by packed sorbent procedure. Analytica Chimica Acta. 661(2); 2010: 222-228.

  • Volosov A, Bialer M, Xiaodong S, Perucca E, Sintov A and Yagen B. Simultaneous stereo selective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiolin human urine. Journal of Chromatography B: Biomedical Sciences and Applications. 738(2); 2000: 419-425.

  • Pienimaki P, Fuchs S, Isojarvi J, Vahakangas K. Improved detection and determination of Carbamazepine and Oxcarbazepine and their metabolites by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 673(1); 1995: 97- 105.

  • Souppart C, Decherf M, Humbert H, Maurer G. Development of a high throughput 9 well plate sample preparation method for the determination of trileptal (Oxcarbazepine) and its metabolites in human plasma, Journal of Chromatography B: Biomedical Sciences and Applications.762(1); 2001: 9-15.

  • Hartley R, Green M, Lucock MD, Ryan S, Forsythe WI. Solid phase extraction of Oxcarbazepine and its metabolites from plasma for analysis by high performance liquid chromatography. Biomedical Chromatography 5(5); 1991: 212-215.

  • Elyas AA, Goldberg VD, Patsalos PN. Simple and rapid micro analytical high performance liquid chromatographic technique for the assay of Oxcarbazepine and its primary active metabolite 10- hydroxyl carbazepine. Journal of Chromatography. 528(2); 1990: 473-479.

  • Wad N. Simultaneous determination of eleven antiepileptic compounds in serum by high performance liquid chromatography. Journal of Chromatography. 305(1); 1994: 127-133.

  • Menge G, Dubois JP. Determination of Oxcarbazepine in human plasma by high performance liquid chromatography. Journal of Chromatography. 275(1); 1983: 189-194.

  • Vermeij TAC, Edelbroek PM. Robust isocratic high performance liquid chromatographic method for 1. simultaneous determination of seven antiepileptic drugs including lamotrigine, Oxcarbazepine and zonisamide in serum after solid phase extraction. Journal of Chromatography B. 857(1); 2007: 40-46.

  • Kimiskidis V, Spanakis M, Niopas I, Kazis D, Gabrieli C, Kanaze FI, Divanoglou D. Development and validation of a high performance liquid chromatographic method for the determination of Oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 43(2); 2007: 763-768.

  • Contin M, Mohamed S, Candela C, Albani F, Riva R, Baruzzi A. Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, Oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. Journal of Chromatography B. 878(3-4); 2010: 461-465.

  • Pranesh Dwivedi, Savita Yadav, Janhavi Rao. Validated RP-HPLC method for the determination of related substance of Oxcarbazepine an antiepileptic drug International Journal of PharmTech Research. 9(3); 2009: 444-451.

  • Rao KS, Belorkar N, Rao MEB. Development and validation of stability indicating liquid chromatographic method for the quantitative determination of Oxcarbazepine in tablet dosage forms. Journal of Young Pharmacists. 1; 2009: 270-277.

  • Qi ML, Wang P, Wang LJ, Fu RN. LC method for the determination of Oxcarbazepine in Pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis. 31; 2003: 57- 62.

  • Bhaumik U, Bose A, Chatterjee B, Ghosh A, Sengupta P, Agarwal S, Das A and Pal TK. Stability indicating HPLC method for the determination of Oxcarbazepine in pharmaceutical formulation. Asian Journal of Chemistry. 22(3); 2010: 2051-2057.

  • Naidu NVS and Sivarami Reddy K. Development and validation of HPLC method for determination of Oxcarbazepine in bulk and pharmaceutical formulation. Analytical Chemistry – an Indian Journal. 15(7); 2015: 243-250.

  • Fortuna A, Sousa J, Alves G, Falcão A, Soares-da-Silva P. Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Analytical and Bioanalytical Chemistry. 397(4); 2010:1605-1615.

  • Pathy KS, Mohan A and Nadakarni S. Analytical techniques in antiepileptic drugs: Determination of assay of Oxcarbazepine by HPLC method. Research & Reviews: Journal of Hospital and Clinical Pharmacy. 3 (1); 2017: 18-35.

  • ICH Q2(R1) Validation of analytical procedures: Text and methodology (2005)

  • ICH Q1A (R2) Stability testing of new drug substances and products (2003).


Abstract Views: 249

PDF Views: 0




  • Stability Indicating HPLC-DAD Method for the Determination of Oxcarbazepine-An Anticonvulsant

Abstract Views: 249  |  PDF Views: 0

Authors

Debi Prasad Pradhan
Department of Pharmaceutical Ananlysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM(Deemed to be University), Vishakapatnam, Andhra Pradesh-530045, India
Mukthinuthalapati Mathrusri Annapurna
Department of Pharmaceutical Ananlysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM(Deemed to be University), Vishakapatnam, Andhra Pradesh-530045, India

Abstract


Oxcarbazepine is an anticonvulsant drug used for the treatment of epilepsy. It acts by decreasing the abnormal electrical activity in the brain. A new stability indicating HPLC method was developed for the quantification of Oxcarbazepine in tablets. Waters e2695 Separations module with Waters 2489 UV detector with Hypersil BDS C18 column (250 mm x 4.6 mm, 5μ) was operated with column temperature 50°C. The detector was monitored at 215 nm and the chromatographic study was run for 20 min. Linearity was observed over 5.0-150 μg/mL with linear regression equation y = 47,910x + 6493.8 with correlation coefficient R² = 0.9999. The LOQ and LOD were found to be 4.5129 μg/mL and 1.4898 μg/mL respectively. Forced degradation studies were performed for Oxcarbazepine capsules and the method was validated as per ICH guidelines.

Keywords


Oxcarbazepine, RP-HPLC, Stability Indicating, Validation, ICH Guidelines.

References